These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35611229)

  • 41. Determinants of stakeholders' intention to adopt pharmacogenomic.
    Mustapa MAC; Amin L; Mahadi Z
    Pharmacogenomics J; 2020 Dec; 20(6):801-812. PubMed ID: 32457399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting.
    Mostafa S; Polasek TM; Sheffield LJ; Huppert D; Kirkpatrick CMJ
    Front Psychiatry; 2021; 12():724170. PubMed ID: 34489765
    [No Abstract]   [Full Text] [Related]  

  • 43. A Scoping Review of Attitudes and Experiences with Pharmacogenomic Testing among Patients and the General Public: Implications for Patient Counseling.
    Allen JD; Pittenger AL; Bishop JR
    J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrating Pharmacogenomics into Clinical Practice: Promise vs Reality.
    St Sauver JL; Bielinski SJ; Olson JE; Bell EJ; Mc Gree ME; Jacobson DJ; McCormick JB; Caraballo PJ; Takahashi PY; Roger VL; Rohrer Vitek CR
    Am J Med; 2016 Oct; 129(10):1093-1099.e1. PubMed ID: 27155109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available.
    Samwald M; Xu H; Blagec K; Empey PE; Malone DC; Ahmed SM; Ryan P; Hofer S; Boyce RD
    PLoS One; 2016; 11(10):e0164972. PubMed ID: 27764192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lay understandings of drug-gene interactions: The right medication, the right dose, at the right time, but what are the right words?
    Meagher KM; Stuttgen Finn K; Curtis SH; Borucki J; Beck AT; Cheema AW; Sharp RR
    Clin Transl Sci; 2022 Mar; 15(3):721-731. PubMed ID: 34755460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physicians' Knowledge, Attitude, and Experience of Pharmacogenomic Testing in China.
    Jia T; Wu C; Hu X; Li S; Zhang X; Cai Y; Chen J; Shi L; Lu CY; Nie X
    J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prescription patterns of outpatients and the potential of multiplexed pharmacogenomic testing.
    Chan SL; Liew HZW; Nguyen F; Thumboo J; Chow WC; Sung C
    Br J Clin Pharmacol; 2021 Mar; 87(3):886-894. PubMed ID: 32559336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
    Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.
    McCarthy MJ; Chen Y; Demodena A; Leckband SG; Fischer E; Golshan S; Suppes T; Kelsoe JR
    J Psychopharmacol; 2021 Aug; 35(8):992-1002. PubMed ID: 33938307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine.
    Tsuji D; Saito Y; Mushiroda T; Miura M; Hira D; Terada T
    J Clin Pharm Ther; 2021 Jun; 46(3):649-657. PubMed ID: 33555613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics.
    Siamoglou S; Koromina M; Hishinuma E; Yamazaki S; Tsermpini EE; Kordou Z; Fukunaga K; Chantratita W; Zhou Y; Lauschke VM; Mushiroda T; Hiratsuka M; Patrinos GP
    Pharmacol Res; 2022 Feb; 176():106087. PubMed ID: 35033648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

  • 54. What Do Students in Pharmacy and Medicine Think About Pharmacogenomics and Personalized Medicine Education? Awareness, Attitudes, and Perceptions in Malaysian Health Sciences.
    Siamoglou S; Koromina M; Moy FM; Mitropoulou C; Patrinos GP; Vasileiou K
    OMICS; 2021 Jan; 25(1):52-59. PubMed ID: 33170085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians.
    Overby CL; Devine EB; Abernethy N; McCune JS; Tarczy-Hornoch P
    J Biomed Inform; 2015 Jun; 55():249-59. PubMed ID: 25957826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantation.
    Deininger KM; Tsunoda SM; Hirsch JD; Anderson H; Lee YM; McIlvennan CK; Page RL; Tran JN; Aquilante CL
    Clin Transplant; 2020 Oct; 34(10):e14037. PubMed ID: 32654213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacogenomic biomarkers: Interpretation of information included in United States and Japanese drug labels.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2018 Aug; 43(4):500-506. PubMed ID: 29722046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenomics at the Point of Care: A Community Pharmacy Project in British Columbia.
    Breaux S; Desrosiers FAD; Neira M; Sinha S; Nislow C
    J Pers Med; 2020 Dec; 11(1):. PubMed ID: 33374349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information.
    Chang JS; Pham DA; Dang MT; Lu Y; VanOsdol S; Shin J
    J Med Libr Assoc; 2016 Jan; 104(1):58-61. PubMed ID: 26807054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the need for pharmacogenomics testing among physicians in the West Bank of Palestine.
    Jarrar Y; Musleh R; Hamdan A; Ghanim M
    Drug Metab Pers Ther; 2021 Jun; 36(4):289-294. PubMed ID: 34821126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.